Improving health outcomes through concurrent HIV program scale-up and health system development in Rwanda: 20years of experience

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Nsanzimana, Sabin ^a,i   Prabhu, Krishna ^b   McDermott, Haley ^c   Karita, Etienne ^h   Forrest, Jamie I ^d,e   Drobac, Peter ^c   Farmer, Paul ^b,c   Mills, Edward J ^e   Binagwaho, Agnes ^b,f,g  

^a RWANDA BIOMEDICAL CENTER   (Rwanda)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PARTNERS IN HEALTH   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Global Evaluative Sciences   (Canada)

^f Ministry of Health of Rwanda   (Rwanda)

^g DARTMOUTH MEDICAL SCHOOL   (United States)

^h Project San Francisco   (Rwanda)

ⁱ UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Antiretroviral therapy; HIV AIDS; Rwanda; Sub Saharan Africa; Universal healthcare

Indexed keywords

DECENTRALIZATION; EPIDEMIC; FUNDING; GENOCIDE; HEALTH CARE; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATION; OUTCOME ASSESSMENT; REVIEW; RWANDA; TUTSI (PEOPLE); VIRUS TRANSMISSION; DEVELOPING COUNTRY; HIV INFECTIONS; MALE;

ANTIRETROVIRUS AGENT;

ANTI-RETROVIRAL AGENTS; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; MALE; RWANDA;

EID: 84941259579     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0443-z     Document Type: Review

References (23)

1. National Institute of Statistics of Rwanda. Statistical Yearbook. http://statistics.gov.rw/publications/statistical-yearbook-2014 . Accessed: March 1, 2015.
2. Binagwaho A, Farmer PE, Nsanzimana S, Karema C, Gasana M, de Dieu NJ, et al. Rwanda 20 years on: investing in life. Lancet. 2014;384:371-5.
3. Farmer PE, Nutt CT, Wagner CM, Sekabaraga C, Nuthulaganti T, Weigel JL, et al. Reduced premature mortality in Rwanda: lessons from success. BMJ. 2013;346:f65.
4. Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, Lopez AD, et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet. 2012;380:2144-62.
5. Nsanzimana S, Kanters S, Remera E, Forrest JI, Binagwaho A, Condo J, et al. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme. Lancet HIV. 2015;2:e208.
6. Dunn D. Nationwide community-based serological survey of HIV-1 and other human retrovirus infections in a Central African country. WHO AIDS Tech Bull. 1989;2:143-4.
7. Nowrojee B. Shattered lives: sexual violence during the Rwandan genocide and its aftermath. Human Rights Watch; 1996. http://www.hrw.org/reports/1996/Rwanda.htm .
8. Donovan P. Rape and HIV/AIDS in Rwanda. Lancet. 2002;360:s17-8.
9. War, oppression, refugee camps fuel spread of HIV. Migration and HIV. Bridge Wash DC 1998;(5):4-5.
10. Reyntjens F. Rwanda: genocide and beyond. J Refugee Stud. 1996;9:240-51.
11. Schieber GJ, Gottret P, Fleisher LK, Leive AA. Financing global health: mission unaccomplished. Health Affairs (Project Hope). 2007;26:921-34.
12. Logie DE, Rowson M, Ndagije F. Innovations in Rwanda's health system: looking to the future. Lancet. 2008;372:256-61.
13. Schneider P, Hanson K. Horizontal equity in utilisation of care and fairness of health financing: a comparison of micro-health insurance and user fees in Rwanda. Health Econ. 2006;15:19-31.
14. Kalk A, Groos N, Karasi JC, Girrbach E. Health systems strengthening through insurance subsidies: the GFATM experience in Rwanda. Trop Med Int Health. 2010;15:94-7.
15. Lu C, Chin B, Lewandowski JL, Basinga P, Hirschhorn LR, Hill K, et al. Towards universal health coverage: an evaluation of Rwanda Mutuelles in its first eight years. PLoS One. 2012;7:e39282.
16. Basinga P, Gertler PJ, Binagwaho A, Soucat AL, Sturdy J, Vermeersch CM. Effect on maternal and child health services in Rwanda of payment to primary health-care providers for performance: an impact evaluation. Lancet. 2011;377:1421-8.
17. Binagwaho A, Condo J, Wagner C, Ngabo F, Karema C, Kanters S, et al. Impact of implementing performance-based financing on childhood malnutrition in Rwanda. BMC Public Health. 2014;14:1132.
18. Nsanzimana S. Benefits of the implementation of the 2013 WHO guidelines on HIV treatment in combination with a test-and-treat strategy for key populations in Rwanda. International HIV Treatment as Prevention Workshop. Vancouver: British Columbia Centre for Excellence in HIV/AIDS; 2014.
19. Nsanzimana S, Remera E, Kanters S, Chan K, Forrest JI, Ford N, et al. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. Lancet Glob Health. 2015;3:e169-77.
20. Franke MF, Kaigamba F, Socci AR, Hakizamungu M, Patel A, Bagiruwigize E, et al. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda. Clin Infect Dis. 2013;56:1319-26.
21. Rich ML, Miller AC, Niyigena P, Franke MF, Niyonzima JB, Socci A, et al. Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda. J Acquir Immune Defic Syndr. 2012;59:e35-42.
22. Shumbusho F, van Griensven J, Lowrance D, Turate I, Weaver MA, Price J, et al. Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda. PLoS Med. 2009;6:e1000163.
23. Binagwaho A, Kyamanywa P, Farmer PE, Nuthulaganti T, Umubyeyi B, Nyemazi JP, et al. The human resources for health program in Rwanda - new partnership. N Engl J Med. 2013;369:2054-9.